ATP2B2ATPase, Ca++ transporting, plasma membrane 2
Autism Reports / Total Reports
12 / 15Rare Variants / Common Variants
24 / 7Aliases
ATP2B2, PMCA2, PMCA2a, PMCA2iAssociated Syndromes
-Chromosome Band
3p25.3Associated Disorders
-Relevance to Autism
Genetic association has been found between the ATP2B2 gene and autism in a combined AGRE, ISART (Italian) and US cohort (Carayol et al., 2011). A de novo missense variant that was predicted to be damaging (p.Thr818Met) was identified in the ATP2B2 gene in an ASD proband from the Simons Simplex Collection in Iossifov et al., 2014, and two de novo nonsense variants in this gene were observed in ASD probands from Japanese trios in Takata et al., 2018. TADA analysis using a combined dataset of previously published cohorts from the Simons Simplex Collection and the Autism Sequencing Consortium, as well as the Japanese ASD cohort from Takata et al., 2018, identified ATP2B2 as a gene significantly enriched in damaging de novo mutations in ASD cases (pBH < 0.05). Functional analysis of the ASD-associated p.Thr818Met missense variant, which was originally identified in an SSC proband, in Drosophila in Marcogliese et al., 2022 demonstrated a loss-of-function effect (failure to reduce expected viability to the extent of corresponding reference allele upon ubiquitous overexpression; wing-specific overexpression of mutant ATP2B2 failed to induce the curled wing phenotype caused by overexpression of reference ATP2B2).
Molecular Function
This gene encodes the plasma membrane calcium ATPase isoform 2. The protein encoded by this gene belongs to the family of P-type primary ion transport ATPases characterized by the formation of an aspartyl phosphate intermediate during the reaction cycle. These enzymes remove bivalent calcium ions from eukaryotic cells against very large concentration gradients and play a critical role in intracellular calcium homeostasis.
External Links
SFARI Genomic Platforms
Reports related to ATP2B2 (15 Reports)
# | Type | Title | Author, Year | Autism Report | Associated Disorders |
---|---|---|---|---|---|
1 | Primary | Converging evidence for an association of ATP2B2 allelic variants with autism in male subjects | Carayol J , et al. (2011) | Yes | - |
2 | Positive Association | The association of rs4307059 and rs35678 markers with autism spectrum disorders is replicated in Italian families | Prandini P , et al. (2012) | Yes | - |
3 | Positive Association | The evidence for association of ATP2B2 polymorphisms with autism in Chinese Han population | Yang W , et al. (2013) | Yes | - |
4 | Recent Recommendation | Haplotype structure enables prioritization of common markers and candidate genes in autism spectrum disorder | Vardarajan BN , et al. (2013) | No | - |
5 | Support | Synaptic, transcriptional and chromatin genes disrupted in autism | De Rubeis S , et al. (2014) | Yes | - |
6 | Support | The contribution of de novo coding mutations to autism spectrum disorder | Iossifov I et al. (2014) | Yes | - |
7 | Positive Association | Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia | Autism Spectrum Disorders Working Group of The Psychiatric Genomics Consortium (2017) | Yes | - |
8 | Support | Exonic Mosaic Mutations Contribute Risk for Autism Spectrum Disorder | Krupp DR , et al. (2017) | Yes | - |
9 | Recent Recommendation | Integrative Analyses of De Novo Mutations Provide Deeper Biological Insights into Autism Spectrum Disorder | Takata A , et al. (2018) | Yes | - |
10 | Support | - | Rodin RE et al. (2021) | Yes | - |
11 | Support | - | Marcogliese PC et al. (2022) | Yes | - |
12 | Support | - | Zhou X et al. (2022) | Yes | - |
13 | Support | - | More RP et al. (2023) | Yes | - |
14 | Recent Recommendation | - | Poggio E et al. (2023) | No | ASD or autistic features, epilepsy/seizures |
15 | Support | - | Thomas V Fernandez et al. (2023) | No | - |
Rare Variants (24)
Status | Allele Change | Residue Change | Variant Type | Inheritance Pattern | Parental Transmission | Family Type | PubMed ID | Author, Year |
---|---|---|---|---|---|---|---|---|
c.1043-19C>T | - | intron_variant | De novo | - | - | 25363760 | De Rubeis S , et al. (2014) | |
c.2511+26G>A | - | intron_variant | De novo | - | - | 25363760 | De Rubeis S , et al. (2014) | |
c.478T>C | p.Ser160Pro | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.707T>A | p.Ile236Asn | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.1801A>G | p.Thr601Ala | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.1903T>G | p.Cys635Gly | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.3634G>A | p.Ala1212Thr | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.2133A>G | p.Pro711%3D | synonymous_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.1330_1332del | p.Phe444del | inframe_deletion | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.2268C>A | p.Cys756Ter | stop_gained | De novo | - | Simplex | 29346770 | Takata A , et al. (2018) | |
c.3191G>A | p.Trp1064Ter | stop_gained | De novo | - | Simplex | 29346770 | Takata A , et al. (2018) | |
c.358G>A | p.Gly120Arg | missense_variant | De novo | - | Simplex | 37675773 | Poggio E et al. (2023) | |
c.2511G>T | p.Met837Ile | missense_variant | De novo | - | Simplex | 37675773 | Poggio E et al. (2023) | |
c.2633T>C | p.Phe878Ser | missense_variant | De novo | - | Simplex | 37675773 | Poggio E et al. (2023) | |
c.3028G>A | p.Glu1010Lys | missense_variant | De novo | - | Simplex | 37675773 | Poggio E et al. (2023) | |
c.2757G>A | p.Thr919= | synonymous_variant | De novo | - | Simplex | 28867142 | Krupp DR , et al. (2017) | |
c.2047C>T | p.Pro683Ser | missense_variant | Familial | - | Multiplex | 36702863 | More RP et al. (2023) | |
c.2453C>T | p.Thr818Met | missense_variant | De novo | - | Simplex | 25363768 | Iossifov I et al. (2014) | |
c.3254dup | p.Thr1086AspfsTer64 | frameshift_variant | De novo | - | Simplex | 37675773 | Poggio E et al. (2023) | |
c.358G>C | p.Gly120Arg | missense_variant | Unknown | Not maternal | Simplex | 37675773 | Poggio E et al. (2023) | |
c.3338_3339del | p.Val1113GlyfsTer36 | frameshift_variant | De novo | - | Simplex | 37675773 | Poggio E et al. (2023) | |
c.3725_3726insCGCTTT | p.Ser1242_Leu1243insAlaLeu | inframe_insertion | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.2577dup | p.Ser860GlnfsTer14 | frameshift_variant | De novo | - | Simplex | 37788244 | Thomas V Fernandez et al. (2023) | |
ENSG00000157087:ENST00000460129:exon11:c.G1817A:p.R606H,ENSG00000157087:ENST00000360273:exon14:c.G19 | - | missense_variant | De novo | - | - | 33432195 | Rodin RE et al. (2021) |
Common Variants (7)
Status | Allele Change | Residue Change | Variant Type | Inheritance Pattern | Paternal Transmission | Family Type | PubMed ID | Author, Year |
---|---|---|---|---|---|---|---|---|
c.2703+9G>T;c.2568+9G>T;c.2610+9G>T;c.2670+9G>T | - | intron_variant | - | - | - | 21757185 | Carayol J , et al. (2011) | |
c.3357G>A;c.3222G>A;c.3264G>A;c.3324G>A | p.(=) | synonymous_variant | - | - | - | 22739633 | Prandini P , et al. (2012) | |
c.1660-296C>T;c.1525-296C>T;c.1567-296C>T;c.1627-296C>T | N/A | intron_variant | - | - | - | 21757185 | Carayol J , et al. (2011) | |
c.2136+3306A>G;c.2001+3306A>G;c.2043+3306A>G;c.2103+3306A>G | C/T | intron_variant | - | - | - | 23620727 | Yang W , et al. (2013) | |
c.2136+3387A>G;c.2001+3387A>G;c.2043+3387A>G;c.2103+3387A>G | N/A | intron_variant | - | - | - | 21757185 | Carayol J , et al. (2011) | |
c.1417-1174C>T;c.1282-1174C>T;c.1324-1174C>T | - | intron_variant | - | - | - | 28540026 | Autism Spectrum Disorders Working Group of The Psychiatric Genomics Consortium (2017) | |
c.1417-1608G>A;c.1282-1608G>A;c.1324-1608G>A | - | intron_variant | - | - | - | 28540026 | Autism Spectrum Disorders Working Group of The Psychiatric Genomics Consortium (2017) |
SFARI Gene score
Strong Candidate
This gene is under a replicated linkage peak at 3p25 (PMID 16205737) and is differentially expressed in lymphoblasts from discordant sib pairs (PMID 19492049). The gene also shows male-specific common variant association (p = 5.3E10-5) after combination of discovery and replication cohorts (PMID 21757185; category score was obtained via category 4.3 with altered expression). A de novo missense variant that was predicted to be damaging was identified in the ATP2B2 gene in an ASD proband from the Simons Simplex Collection in Iossifov et al., 2014, and two de novo nonsense variants in this gene were observed in ASD probands from Japanese trios in Takata et al., 2018. TADA analysis using a combined dataset of previously published cohorts from the Simons Simplex Collection and the Autism Sequencing Consortium, as well as the Japanese ASD cohort from Takata et al., 2018, identified ATP2B2 as a gene significantly enriched in damaging de novo mutations in ASD cases (pBH < 0.05).
Score Delta: Score remained at 2
criteria met
See SFARI Gene'scoring criteriaWe considered a rigorous statistical comparison between cases and controls, yielding genome-wide statistical significance, with independent replication, to be the strongest possible evidence for a gene. These criteria were relaxed slightly for category 2.
1/1/2021
Score remained at 2
Description
This gene is under a replicated linkage peak at 3p25 (PMID 16205737) and is differentially expressed in lymphoblasts from discordant sib pairs (PMID 19492049). The gene also shows male-specific common variant association (p = 5.3E10-5) after combination of discovery and replication cohorts (PMID 21757185; category score was obtained via category 4.3 with altered expression). A de novo missense variant that was predicted to be damaging was identified in the ATP2B2 gene in an ASD proband from the Simons Simplex Collection in Iossifov et al., 2014, and two de novo nonsense variants in this gene were observed in ASD probands from Japanese trios in Takata et al., 2018. TADA analysis using a combined dataset of previously published cohorts from the Simons Simplex Collection and the Autism Sequencing Consortium, as well as the Japanese ASD cohort from Takata et al., 2018, identified ATP2B2 as a gene significantly enriched in damaging de novo mutations in ASD cases (pBH < 0.05).
10/1/2019
Decreased from 3 to 2
New Scoring Scheme
Description
This gene is under a replicated linkage peak at 3p25 (PMID 16205737) and is differentially expressed in lymphoblasts from discordant sib pairs (PMID 19492049). The gene also shows male-specific common variant association (p = 5.3E10-5) after combination of discovery and replication cohorts (PMID 21757185; category score was obtained via category 4.3 with altered expression). A de novo missense variant that was predicted to be damaging was identified in the ATP2B2 gene in an ASD proband from the Simons Simplex Collection in Iossifov et al., 2014, and two de novo nonsense variants in this gene were observed in ASD probands from Japanese trios in Takata et al., 2018. TADA analysis using a combined dataset of previously published cohorts from the Simons Simplex Collection and the Autism Sequencing Consortium, as well as the Japanese ASD cohort from Takata et al., 2018, identified ATP2B2 as a gene significantly enriched in damaging de novo mutations in ASD cases (pBH < 0.05).
Reports Added
[New Scoring Scheme]10/1/2017
Decreased from 3 to 3
Description
This gene is under a replicated linkage peak at 3p25 (PMID 16205737) and is differentially expressed in lymphoblasts from discordant sib pairs (PMID 19492049). The gene also shows male-specific common variant association (p = 5.3E10-5) after combination of discovery and replication cohorts (PMID 21757185; category score was obtained via category 4.3 with altered expression).
4/1/2017
Decreased from 3 to 3
Description
This gene is under a replicated linkage peak at 3p25 (PMID 16205737) and is differentially expressed in lymphoblasts from discordant sib pairs (PMID 19492049). The gene also shows male-specific common variant association (p = 5.3 ? 10?5) after combination of discovery and replication cohorts (PMID 21757185; category score was obtained via category 4.3 with altered expression).
Reports Added
[The association of rs4307059 and rs35678 markers with autism spectrum disorders is replicated in Italian families.2012] [The evidence for association of ATP2B2 polymorphisms with autism in Chinese Han population.2013] [Converging evidence for an association of ATP2B2 allelic variants with autism in male subjects.2011] [Haplotype structure enables prioritization of common markers and candidate genes in autism spectrum disorder.2013] [Synaptic, transcriptional and chromatin genes disrupted in autism.2014] [The contribution of de novo coding mutations to autism spectrum disorder2014] [Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with ...2017]1/1/2016
Decreased from 3 to 3
Description
This gene is under a replicated linkage peak at 3p25 (PMID 16205737) and is differentially expressed in lymphoblasts from discordant sib pairs (PMID 19492049). The gene also shows male-specific common variant association (p = 5.3 ? 10?5) after combination of discovery and replication cohorts (PMID 21757185; category score was obtained via category 4.3 with altered expression).
Reports Added
[The association of rs4307059 and rs35678 markers with autism spectrum disorders is replicated in Italian families.2012] [The evidence for association of ATP2B2 polymorphisms with autism in Chinese Han population.2013] [Converging evidence for an association of ATP2B2 allelic variants with autism in male subjects.2011] [Haplotype structure enables prioritization of common markers and candidate genes in autism spectrum disorder.2013] [Synaptic, transcriptional and chromatin genes disrupted in autism.2014] [The contribution of de novo coding mutations to autism spectrum disorder2014]7/1/2014
Increased from No data to 3
Description
This gene is under a replicated linkage peak at 3p25 (PMID 16205737) and is differentially expressed in lymphoblasts from discordant sib pairs (PMID 19492049). The gene also shows male-specific common variant association (p = 5.3 ? 10?5) after combination of discovery and replication cohorts (PMID 21757185; category score was obtained via category 4.3 with altered expression).
4/1/2014
Increased from No data to 3
Description
This gene is under a replicated linkage peak at 3p25 (PMID 16205737) and is differentially expressed in lymphoblasts from discordant sib pairs (PMID 19492049). The gene also shows male-specific common variant association (p = 5.3 ? 10?5) after combination of discovery and replication cohorts (PMID 21757185; category score was obtained via category 4.3 with altered expression).
Krishnan Probability Score
Score 1
Ranking 1/25841 scored genes
[Show Scoring Methodology]
ExAC Score
Score 0.99992150647326
Ranking 646/18225 scored genes
[Show Scoring Methodology]
Sanders TADA Score
Score 0.9443141799457
Ranking 16027/18665 scored genes
[Show Scoring Methodology]
Larsen Cumulative Evidence Score
Score 5
Ranking 274/461 scored genes
[Show Scoring Methodology]
Zhang D Score
Score 0.35379125541735
Ranking 1967/20870 scored genes
[Show Scoring Methodology]
External PIN Data
Interactome
- Protein Binding
- DNA Binding
- RNA Binding
- Protein Modification
- Direct Regulation
- ASD-Linked Genes
Interaction Table
Interactor Symbol | Interactor Name | Interactor Organism | Interactor Type | Entrez ID | Uniprot ID |
---|---|---|---|---|---|
ABCB9 | ADORA2A | Human | Protein Binding | 23457 | Q9NP78 |
ABCC10 | ATP-binding cassette, sub-family C (CFTR/MRP), member 10 | Human | Protein Binding | 89845 | Q5T3U5 |
ABCC4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 | Human | Protein Binding | 10257 | O15439 |
ABCD1 | AGBL4 | Human | Protein Binding | 215 | P33897 |
ABCD4 | ATP-binding cassette sub-family D member 4 | Human | Protein Binding | 5826 | O14678 |
ADAMTS4 | ASS1 | Human | Protein Binding | 9507 | O75173 |
ALG10 | ALG10, alpha-1,2-glucosyltransferase | Human | Protein Binding | 84920 | Q5BKT4 |
ALG8 | ALG8, alpha-1,3-glucosyltransferase | Human | Protein Binding | 79053 | A6NDW6 |
Ania-3/Homer | homer homolog 1 (Drosophila) | Rat | Protein Binding | 29546 | Q9Z214 |
APOD | Apolipoprotein D | Human | Protein Binding | 347 | P05090 |
ARL6IP1 | ADP-ribosylation factor-like 6 interacting protein 1 | Human | Protein Binding | 23204 | Q15041 |
ATG9A | autophagy related 9A | Human | Protein Binding | 79065 | Q7Z3C6 |
ATP2B3 | Plasma membrane calcium-transporting ATPase 3 | Human | Protein Binding | 492 | Q16720-2 |
ATP9A | ATPase, class II, type 9A | Human | Protein Binding | 10079 | O75110 |
ATPBD4 | diphthamine biosynthesis 6 | Human | Protein Binding | NM_001141972 | Q7L8W6 |
AZGP1 | Zinc-alpha-2-glycoprotein | Human | Protein Binding | 563 | P25311 |
BCAP31 | B-cell receptor-associated protein 31 | Human | Protein Binding | 10134 | P51572 |
BRP44 | mitochondrial pyruvate carrier 2 | Human | Protein Binding | NM_015415 | A0A024R8Z5 |
BTBD9 | BTB (POZ) domain containing 9 | Human | Protein Binding | 114781 | Q96Q07 |
C12ORF49 | chromosome 12 open reading frame 49 | Human | Protein Binding | 79794 | Q9H741 |
C6ORF72 | glycoprotein integral membrane 1 | Human | Protein Binding | 116254 | Q9NU53 |
CD79B | B-cell antigen receptor complex-associated protein beta chain | Human | Protein Binding | 974 | P40259-2 |
CD83 | ITGB7 | Human | Protein Binding | 9308 | Q01151 |
CHSY1 | chondroitin sulfate synthase 1 | Human | Protein Binding | 22856 | Q86X52 |
CLU | clusterin | Human | Protein Binding | 1191 | P10909 |
CYP2B6 | Cytochrome P450 2B6 | Human | Protein Binding | 1555 | P20813 |
DGAT1 | PCDHA13 | Human | Protein Binding | 8694 | O75907 |
DHRS7 | Dehydrogenase/reductase SDR family member 7 | Human | Protein Binding | 51635 | Q9Y394-2 |
DHRS9 | Dehydrogenase/reductase SDR family member 9 | Human | Protein Binding | 10170 | Q9BPW9 |
DLG1 | discs, large homolog 1 (Drosophila) | Human | Protein Binding | 1739 | Q12959 |
EDNRB | Endothelin B receptor | Human | Protein Binding | 1910 | P24530-3 |
EFNB2 | ephrin-B2 | Human | Protein Binding | 1948 | P52799 |
ENTPD7 | ectonucleoside triphosphate diphosphohydrolase 7 | Human | Protein Binding | 57089 | Q9NQZ7 |
ERMP1 | endoplasmic reticulum metallopeptidase 1 | Human | Protein Binding | 79956 | B3KSB1 |
FAM174A | Membrane protein FAM174A | Human | Protein Binding | 345757 | Q8TBP5 |
FAR2 | fatty acyl CoA reductase 2 | Human | Protein Binding | 55711 | Q96K12 |
FPR2 | N-formyl peptide receptor 2 | Human | Protein Binding | 2358 | P25090 |
FZD10 | TYR | Human | Protein Binding | 11211 | Q6NSL8 |
FZD7 | frizzled family receptor 7 | Human | Protein Binding | 8324 | O75084 |
GALNT6 | UBR7 | Human | Protein Binding | 11226 | Q8NCL4 |
GLB1L2 | Beta-galactosidase-1-like protein 2 | Human | Protein Binding | 89944 | Q8IW92 |
GOLGA5 | golgin A5 | Human | Protein Binding | 9950 | Q8TBA6 |
GOLIM4 | golgi integral membrane protein 4 | Human | Protein Binding | 27333 | O00461 |
GOLM1 | golgi membrane protein 1 | Human | Protein Binding | 51280 | B3KNK9 |
GPAM | Human | Protein Binding | |||
GPR161 | G protein-coupled receptor 161 | Human | Protein Binding | 23432 | B7Z5Z6 |
GPR89A | Golgi pH regulator A | Human | Protein Binding | 51463 | B7ZAQ6-2 |
GRIN2A | glutamate receptor, ionotropic, N-methyl D-aspartate 2A | Rat | Protein Binding | 24409 | Q00959 |
HSD17B6 | 17-beta-hydroxysteroid dehydrogenase type 6 | Human | Protein Binding | 8630 | O14756 |
HTR2C | 5-hydroxytryptamine receptor 2C | Human | Protein Binding | 3358 | P28335 |
HTR3A | 5-hydroxytryptamine receptor 3A | Human | Protein Binding | 3359 | P46098-2 |
IL1R2 | Human | Protein Binding | |||
IL29 | Interferon lambda-1 | Human | Protein Binding | 282618 | Q8IU54 |
LASS6 | Ceramide synthase 6 | Human | Protein Binding | 253782 | Q6ZMG9 |
LCLAT1 | lysocardiolipin acyltransferase 1 | Human | Protein Binding | 253558 | Q6UWP7 |
LEMD2 | LEM domain containing 2 | Human | Protein Binding | 221496 | Q8NC56 |
LGALS8 | Galectin-8 | Human | Protein Binding | 3964 | O00214 |
LILRB4 | Leukocyte immunoglobulin-like receptor subfamily B member 4 | Human | Protein Binding | 11006 | Q8NHJ6-2 |
MAOB | Amine oxidase [flavin-containing] B | Human | Protein Binding | 4129 | P27338 |
MUCL1 | Mucin-like protein 1 | Human | Protein Binding | 118430 | Q96DR8 |
NOS3 | nitric oxide synthase 3 (endothelial cell) | Human | Protein Binding | 4846 | P60323 |
NRM | Human | Protein Binding | |||
OSTC | oligosaccharyltransferase complex subunit (non-catalytic) | Human | Protein Binding | 58505 | Q9NRP0 |
PCDHGB1 | Protocadherin gamma-B1 | Human | Protein Binding | 56104 | Q9Y5G3-2 |
PCNXL3 | pecanex-like 3 (Drosophila) | Human | Protein Binding | 399909 | Q9H6A9 |
PDZD11 | PDZ domain containing 11 | Human | Protein Binding | 51248 | Q5EBL8 |
PIGN | phosphatidylinositol glycan anchor biosynthesis, class N | Human | Protein Binding | 23556 | O95427 |
PIGO | phosphatidylinositol glycan anchor biosynthesis, class O | Human | Protein Binding | 84720 | Q8TEQ8 |
PRKCA | protein kinase C, alpha | Rat | Protein Modification | 24680 | Q9EP80 |
PTGFR | Prostaglandin F2-alpha receptor | Human | Protein Binding | 5737 | P43088 |
PTGIR | Prostacyclin receptor | Human | Protein Binding | 5739 | P43119 |
RHOT2 | ras homolog family member T2 | Human | Protein Binding | 89941 | Q8IXI1 |
SCARA3 | Scavenger receptor class A member 3 | Human | Protein Binding | 51435 | Q6AZY7-2 |
SDF4 | stromal cell derived factor 4 | Human | Protein Binding | 51150 | Q9BRK5 |
SLC15A4 | solute carrier family 15, member 4 | Human | Protein Binding | 121260 | Q8N697 |
SLC22A16 | Solute carrier family 22 member 16 | Human | Protein Binding | 85413 | Q86VW1 |
SLC26A6 | Solute carrier family 26 member 6 | Human | Protein Binding | 65010 | Q9BXS9-2 |
SLC2A5 | solute carrier family 2 (facilitated glucose/fructose transporter), member 5 | Human | Protein Binding | 6518 | P22732 |
SLC38A9 | Sodium-coupled neutral amino acid transporter 9 | Human | Protein Binding | 153129 | Q8NBW4-2 |
SLC45A2 | Membrane-associated transporter protein | Human | Protein Binding | 51151 | D6RGY6 |
SLC4A2 | solute carrier family 4, anion exchanger, member 2 (erythrocyte membrane protein band 3-like 1) | Human | Protein Binding | 6522 | P04920 |
SLC4A7 | solute carrier family 4, sodium bicarbonate cotransporter, member 7 | Human | Protein Binding | 9497 | B5M449 |
SNTA1 | syntrophin, alpha 1 | Human | Protein Binding | 6640 | Q13424 |
SPACA1 | Sperm acrosome membrane-associated protein 1 | Human | Protein Binding | 81833 | Q9HBV2 |
SQLE | squalene epoxidase | Human | Protein Binding | 6713 | Q14534 |
ST3GAL1 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | Human | Protein Binding | 6482 | Q11201 |
STEAP3 | STEAP family member 3, metalloreductase | Human | Protein Binding | 55240 | Q658P3 |
TIMM23 | translocase of inner mitochondrial membrane 23 homolog (yeast) | Human | Protein Binding | 100287932 | O14925 |
TMEM168 | transmembrane protein 168 | Human | Protein Binding | 64418 | Q9H0V1 |
TMEM5 | Transmembrane protein 5 | Human | Protein Binding | 10329 | Q9Y2B1 |
TMEM63A | CSC1-like protein 1 | Human | Protein Binding | 9725 | O94886 |
TMEM63B | transmembrane protein 63B | Human | Protein Binding | 55362 | Q5T3F8 |
TNPO3 | transportin 3 | Human | Protein Binding | 23534 | B3KMX1 |
TOR1A | torsin family 1, member A (torsin A) | Human | Protein Binding | 1861 | O14656 |
TRABD | TraB domain containing | Human | Protein Binding | 80305 | Q9H4I3 |
VAC14 | Vac14 homolog (S. cerevisiae) | Human | Protein Binding | 55697 | Q08AM6 |
VAV1 | Human | Protein Binding | |||
VSIG4 | V-set and immunoglobulin domain-containing protein 4 | Human | Protein Binding | 11326 | Q9Y279 |